Bayer is deepening its involvement in CRISPR with a licensing agreement for genome editing patents. Irish...
Up To Date
Latest News
Newly spun out company OxStem has raised £16.9m (€21.5m) to develop regenerative meds for the treatment of...
Swiss Genentech partner AC Immune has raised CHF42.7m (€38.6m) in order to advance its therapeutic and...
Ipsen is strengthening its ties to long-time development partner Oncodesign, a Dijon-based cancer treatment...
Swiss bank Group UBS has raised US$471m (€412m) for the UBS Oncology Impact Fund, which was set up to invest...
An expert panel’s final report on the fatal drug trial earlier this year in France states that the death of...